248 related articles for article (PubMed ID: 14598319)
1. Mice lacking tissue plasminogen activator and urokinase plasminogen activator genes show attenuated matrix metalloproteases activity after sciatic nerve crush.
Siconolfi LB; Seeds NW
J Neurosci Res; 2003 Nov; 74(3):430-4. PubMed ID: 14598319
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activators are involved in the degradation of bone by osteoclasts.
Everts V; Daci E; Tigchelaar-Gutter W; Hoeben KA; Torrekens S; Carmeliet G; Beertsen W
Bone; 2008 Nov; 43(5):915-20. PubMed ID: 18691680
[TBL] [Abstract][Full Text] [Related]
3. Induction of the plasminogen activator system accompanies peripheral nerve regeneration after sciatic nerve crush.
Siconolfi LB; Seeds NW
J Neurosci; 2001 Jun; 21(12):4336-47. PubMed ID: 11404419
[TBL] [Abstract][Full Text] [Related]
4. ACE inhibition reduces activity of the plasminogen/plasmin and MMP systems in the brain of spontaneous hypertensive stroke-prone rats.
Liebetrau M; Burggraf D; Wunderlich N; Jäger G; Linz W; Hamann GF
Neurosci Lett; 2005 Mar; 376(3):205-9. PubMed ID: 15721222
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator.
Wang X; Lee SR; Arai K; Lee SR; Tsuji K; Rebeck GW; Lo EH
Nat Med; 2003 Oct; 9(10):1313-7. PubMed ID: 12960961
[TBL] [Abstract][Full Text] [Related]
6. Changes to plasminogen activators and matrix metalloproteinase-9 in dogs with toxocarosis.
Lai SC; Chen KM
Vet Parasitol; 2007 Nov; 150(1-2):122-7. PubMed ID: 17913363
[TBL] [Abstract][Full Text] [Related]
7. IGF-II/mannose 6-phosphate receptor activation induces metalloproteinase-9 matrix activity and increases plasminogen activator expression in H9c2 cardiomyoblast cells.
Chang MH; Kuo WW; Chen RJ; Lu MC; Tsai FJ; Kuo WH; Chen LY; Wu WJ; Huang CY; Chu CH
J Mol Endocrinol; 2008 Aug; 41(2):65-74. PubMed ID: 18495691
[TBL] [Abstract][Full Text] [Related]
8. Disruption of tissue plasminogen activator gene reduces macrophage migration.
Ling C; Zou T; Hsiao Y; Tao X; Chen ZL; Strickland S; Song H
Biochem Biophys Res Commun; 2006 Oct; 349(3):906-12. PubMed ID: 16978586
[TBL] [Abstract][Full Text] [Related]
9. Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue.
Knappe UJ; Hagel C; Lisboa BW; Wilczak W; Lüdecke DK; Saeger W
Acta Neuropathol; 2003 Nov; 106(5):471-8. PubMed ID: 12904990
[TBL] [Abstract][Full Text] [Related]
10. Extracellular matrix and matrix metalloproteinases in sciatic nerve.
Platt CI; Krekoski CA; Ward RV; Edwards DR; Gavrilovic J
J Neurosci Res; 2003 Nov; 74(3):417-29. PubMed ID: 14598318
[TBL] [Abstract][Full Text] [Related]
11. Mice lacking tPA, uPA, or plasminogen genes showed delayed functional recovery after sciatic nerve crush.
Siconolfi LB; Seeds NW
J Neurosci; 2001 Jun; 21(12):4348-55. PubMed ID: 11404420
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis.
Heymans S; Pauschinger M; De Palma A; Kallwellis-Opara A; Rutschow S; Swinnen M; Vanhoutte D; Gao F; Torpai R; Baker AH; Padalko E; Neyts J; Schultheiss HP; Van de Werf F; Carmeliet P; Pinto YM
Circulation; 2006 Aug; 114(6):565-73. PubMed ID: 16880329
[TBL] [Abstract][Full Text] [Related]
13. Expression and localisation of extracellular matrix degrading proteases and their inhibitors during the oestrous cycle and after induced luteolysis in the bovine corpus luteum.
Kliem H; Welter H; Kraetzl WD; Steffl M; Meyer HH; Schams D; Berisha B
Reproduction; 2007 Sep; 134(3):535-47. PubMed ID: 17709571
[TBL] [Abstract][Full Text] [Related]
14. Integrin alpha(v)beta(3), metalloproteinases, and sphingomyelinase-2 mediate urokinase mitogenic effect.
Maupas-Schwalm F; Bedel A; Augé N; Grazide MH; Mucher E; Thiers JC; Salvayre R; Nègre-Salvayre A
Cell Signal; 2009 Dec; 21(12):1925-34. PubMed ID: 19735728
[TBL] [Abstract][Full Text] [Related]
15. Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model.
Deatrick KB; Eliason JL; Lynch EM; Moore AJ; Dewyer NA; Varma MR; Pearce CG; Upchurch GR; Wakefield TW; Henke PK
J Vasc Surg; 2005 Jul; 42(1):140-8. PubMed ID: 16012463
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma.
Naka T; Kuester D; Boltze C; Schulz TO; Samii A; Herold C; Ostertag H; Roessner A
Hum Pathol; 2008 Feb; 39(2):217-23. PubMed ID: 17949787
[TBL] [Abstract][Full Text] [Related]
17. Microglial low-density lipoprotein receptor-related protein 1 mediates the effect of tissue-type plasminogen activator on matrix metalloproteinase-9 activity in the ischemic brain.
Zhang C; An J; Haile WB; Echeverry R; Strickland DK; Yepes M
J Cereb Blood Flow Metab; 2009 Dec; 29(12):1946-54. PubMed ID: 19672275
[TBL] [Abstract][Full Text] [Related]
18. Increased bone formation in mice lacking plasminogen activators.
Daci E; Everts V; Torrekens S; Van Herck E; Tigchelaar-Gutterr W; Bouillon R; Carmeliet G
J Bone Miner Res; 2003 Jul; 18(7):1167-76. PubMed ID: 12854826
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator expression correlates with genetic differences in vascular remodeling.
Korshunov VA; Solomatina MA; Plekhanova OS; Parfyonova YV; Tkachuk VA; Berk BC
J Vasc Res; 2004; 41(6):481-90. PubMed ID: 15528930
[TBL] [Abstract][Full Text] [Related]
20. Tissue-type plasminogen activator depletion affects the nasal mucosa matrix reconstruction in allergic rhinitis mice.
Hua H; Zhang R; Yu S; Wang H; Zhao Y; Yu S; Li W
Allergol Immunopathol (Madr); 2011; 39(4):206-11. PubMed ID: 21339035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]